Viracta Therapeutics Company
Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.
Technology:
Cancer
Funding Status:
IPO
Investor Type:
IPO
Investors Number:
19
Employee Number:
11-50
Last Funding Date:
2021
Headquarters:
Cardiff By The Sea, California, United States
Last Funding Type:
Post-IPO Equity
Total Funding:
184899999
Founded Date:
2007
Industry:
Biopharma, Biotechnology, Medical, Pharmaceutical, Therapeutics
Estimated Revenue:
$10M to $50M